Willingness to Use and Pay for a New Diagnostic Test for Acute Lower Respiratory Infection: Results from Benin, Peru, and Tanzania

File Type: PDF | File Size: 3.46 MB

This study examined people’s willingness (and ability) to purchase a new diagnostic test for acute lower respiratory infections (ALRI), a major cause of childhood morbidity and mortality in developing countries. ALRI can be treated, but diagnosis is complex; requires advanced laboratory tools; and can be delayed by equipment breakdowns, which may ultimately lead to death. Health care providers and consumers showed little interest in this test, suggesting a limited market. More interest was shown in promoting prevention (e.g., new vaccines). The authors recommend efforts to subsidize the price of new vaccines to facilitate their adoption in national immunization schedules but also caution that as vaccines preventing the principal causes of severe pneumonia spread and other pathogens more prevalent, current diagnostic criteria may become irrelevant, and having new technology in place would be valuable.

Publication Date 
June 2009
Resource Type 
Research Reports
Regions/ Countries